Quarterly report [Sections 13 or 15(d)]

Cash, Cash Equivalents, and Marketable Securities (Tables)

v3.26.1
Cash, Cash Equivalents, and Marketable Securities (Tables)
3 Months Ended
Mar. 31, 2026
Cash, Cash Equivalents, and Marketable Securities [Abstract]  
Schedule of Company’s Investments

The following table summarizes the Company’s investments as of March 31, 2026 (in thousands):

 

    Amortized
Cost Basis
    Unrealized
Gains
    Unrealized
Losses
    Estimated
Fair Value
 
                         
Cash   $ 37,371     $
-
    $
             -
    $ 37,371  
Investments in corporate bonds     17,210       5               17,215  
Total cash, cash equivalents and investments in marketable securities   $ 54,581     $ 5     $
-
    $ 54,586  

 

 

The following table summarizes the Company’s investments as of December 31, 2025 (in thousands):

 

    Amortized
Cost Basis
    Unrealized
Gains
    Unrealized
Losses
    Estimated
Fair Value
 
                         
Cash   $ 24,172     $
-
    $
               -
    $ 24,172  
U.S. Treasury Bills     3,449      
-
     
-
      3,449  
Money Market     1,577                       1,577  
Investments in corporate bonds     12,072      
-
      (1 )     12,071  
Total cash, cash equivalents and investments in marketable securities   $ 41,270     $
-
    $ (1 )   $ 41,269